<DOC>
	<DOCNO>NCT00702208</DOCNO>
	<brief_summary>The aim study see whether new self-sampling device , Delphi Screener ( Delphi Devices , Scherpenzeel , Netherlands ) , use cervical cancer screening . The result use new device compare result use current gold standard . The gold standard clinician-collected endo-cervical ecto-cervical specimen ( often refer 'Pap smear ' ) . Additionally , woman ask acceptability use device easy understand user instruction . The Delphi Screener sterile , plastic , syringe-like device contain buffer saline allows woman collect vaginal lavage ( 'self-squirt ' ) . The hypothesis device may work well cervical cytology acceptable woman study .</brief_summary>
	<brief_title>Feasibility Delphi Screener Cervical Cytology</brief_title>
	<detailed_description />
	<criteria>Valid Pap smear last 13 month obtain participate clinic 18 year old Selfreport able read English and/or Spanish Willing sign inform consent Used vaginal product ( douche , spermicide , antifungal ) last 48 hour Last menses start â‰¤ 4 day prior enrollment visit No uterus / history hysterectomy Selfreport currently pregnant Selfreport currently breastfeed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>cervical cytology</keyword>
	<keyword>Pap smear</keyword>
	<keyword>self-sampling</keyword>
	<keyword>abnormal</keyword>
	<keyword>normal</keyword>
</DOC>